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Background: Mycoplasma pneumoniae is a common cause of community-acquired pneumonia (CAP) in children.
The aim of this study was to assess the prevalence of Mycoplasma pneumoniae infection in children with CAP
and find clinical, radiological and laboratory features helpful to diagnose Mycoplasma pneumoniae pneumonia.
Furthermore, we evaluated the value of serology, real-time PCR (RT-PCR) and culture for the accurate diagnosis of
Mycoplasma pneumoniae pneumonia.
Methods: The study included 166 children aged between 1 and 15 years with radiologically confirmed pneumonia.
Throat swab specimens were cultured and assessed by RT-PCR for the presence of Mycoplasma pneumoniae.
Mycoplasma pneumoniae-specific IgM and IgG antibodies were determined using ELISA in paired sera.
Results: Mycoplasma pneumoniae pneumonia was diagnosed in 14.5% CAP cases. Cough (p=0.029), headache
(p=0.001) and wheezing (p=0.036) were more frequent in children with Mycoplasma pneumoniae pneumonia
compared to children with pneumonia caused by other pathogens. Logistic regression analysis showed that
headache (odds ratio [OR] =36.077, p=0.001) and wheezing (OR=5.681, p=0.003) were significantly associated with
MP pneumonia. Neither radiological findings, nor common laboratory parameters distinguished Mycoplasma
pneumoniae infection in children with CAP. Using IgG serology in paired sera as the gold standard, we found that
sensitivity of IgM serology, RT-PCR and culture was equal (81.82%), while specificity values were 100%, 98.6% and
100% respectively. We observed that combination of IgM detection in acute-phase serum and RT-PCR was positive
for 91.7% of cases with Mycoplasma pneumoniae infection.
Conclusions: There are no characteristic radiological findings, or routine laboratory tests that would distinguish
CAP caused by Mycoplasma pneumoniae from other CAP. It was found that clinical features such as headache and
wheezing are indicative for Mycoplasma pneumoniae infection. Furthermore, it was found that during the acute
phase of disease, detection of IgM antibodies in combination with RT-PCR allows for precise and reliable diagnosis
of Mycoplasma pneumoniae infections in children.
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Mycoplasma pneumoniae (MP) causes up to 40% of
community-acquired pneumonia (CAP) in children and
about 18% of infections in patients requiring hospitalization
[1]. In the majority of cases of suspected MP pneumonia,
the presumptive diagnosis is made on clinical and radio-
logical findings alone. However, MP is not susceptible to
the β-lactam antibiotics regularly used for the treatment of
pediatric pneumonia [2], therefore a specific diagnostic tool
is extremely important. Laboratory diagnosis of MP infec-
tion in clinical practice have been based on serology, cul-
ture and polymerase chain reaction (PCR), although each
of them has specific limitations [3].
In Serbia, however, diagnosis of MP infection is most
often based on serology. Consequently, the precise inci-
dence of MP infection in children with CAP remains un-
known. Therefore, we conducted a study to assess the
incidence of MP pneumonia, define clinical, radiological
and laboratory features specific for MP pneumonia and to
evaluate the value of serology, real-time PCR (RT-PCR)
and culture for the accurate diagnosis of MP pneumonia.
Methods
Study population
Previously healthy children aged between 1 and 15 years
with symptoms, signs and chest radiographs consistent
with community-acquired pneumonia examined in the
Emergency department of University Children? s Hospital in
Belgrade from April 2012 to March 2014 were prospect-
ively enrolled in this study. Pneumonia was defined as the
presence of fever, acute respiratory symptoms (cough, tach-
ypnoea, difficult breathing) or both, plus presence of new
infiltrate on chest radiography or consolidation not attrib-
utable to some other aetiology [4]. Children who received
anti-mycoplasma therapy were excluded from the study.
This study was approved by Ethics Committee of Univer-
sity Children? s Hospital in Belgrade. Patients were enrolled
in study after written informed consent had been obtained
from their parents or guardians.
Demographic and clinical data were collected uni-
formly from all children who were included in the study.
Chest radiographs were taken and reviewed by pediatric
radiologist. Radiological findings were classified as inter-
stitial infiltration, linear opacities, patchy infiltration,
segmental or lobar consolidation, reticulo-nodular infil-
trate or pleural effusion [5]. Throat swabs taken at enrol-
ment were cultured and assessed by RT-PCR. Blood
samples were obtained at the time of enrolment and
two to four weeks after. White blood cell (WBC) count,
C-reactive protein (CRP) and serological tests were per-
formed at enrolment. The patients were hospitalized on
the basis of the clinical decision of the pediatricians on
duty. Data regarding clinical course of illness were also
recorded.Culture methods
Clinical specimens were inoculated on PPLO (Pleuro
pneumonia like organisms) broth and agar bases (HiMe-
dia, HiMedia Laboratories, Mumbai, India) supple-
mented with Mycoplasma supplements (HiMedia) and
glucose (0.1%) (HiMedia). The cultures were incubated
at 37?C in an atmosphere of 5% CO 2 and 95% air. The
broth cultures were observed daily for 21 days and the
growth of MP is indicated by phenol red (acid produc-
tion because of glucose degradation leads to a yellowing
of the broth). The agar cultures were examined micro-
scopically after 21 days of incubation for the presence of
typical colonies (the isolated colonies were identified by
their characteristic homogeneous granular appearance
and stained with Diene ? s staining).
DNA extraction
The Qiagen QIAamp DNA minikit (QIAGEN, Hilden,
Germany) was used for nucleic acid extraction from exam-
ined respiratory specimens according to the manufacturer ? s
instructions. The elution volume was reduced to 30 μl.
Real-time PCR
Each nucleic acid extract from examined respiratory speci-
mens was tested with our in-house real-time PCR assay.
This method, targeting a 125-bp fragment of the M. pneu-
moniae P1 cytadhesin gene, was performed using the
primers P1-204 [5′-GTGAACGTATCGTAACACGAGCT
TT-3′), P1-328 (5′-TGGTTTGTTGACTGCCACTGC-
3′], the TaqMan probe P1-284R [5′-TAM-TTGTCGCGC
ACTAAGGCCCACG-MGB-3′], and a commercial in-
ternal control (IC), the TaqMan exogenous internal posi-
tive control (VIC dye) (Applied Biosystems, Foster City,
USA). Real-time PCR was performed in 25 μl of a reaction
mixture consisting of 12.5 μl of 2X TaqMan universal PCR
master mix (Applied Biosystems, Foster City, USA),
0.9 μM of each primer, 0.25 μM of probe, 0.5 μl of IC
DNA, 2.5 μl of IC primers/probe, and 5 μl of extracted
DNA. Amplifications were performed using a Applied
Biosystems 7500 Real-Time PCR system (Applied Biosys-
tems, Foster City, USA) under the following conditions:
2 min at 50?C and 10 min at 95?C, followed by 45 cycles
of 15 s at 95?C and 1 min at 60?C.
Serological testing
Serum was separated from the venous blood samples
and stored at -20C? till assayed. For detection of MP
antibodies, a commercially available IgM and an IgG
enzyme-linked immunosorbent assay (ELISA Euroimmun,
L?beck, Germany) were performed. The serological
diagnosis was defined when IgM antibodies were de-
tected (>1.1) in single serum or if at least 4-fold increase
in the IgG antibody titer was detected in the paired
sera.
Table 1 Comparison of the demographic and clinical data
between children with Mycoplasma pneumoniae
pneumonia and in children with pneumonia caused by










Males 75 47.9 p=0.014
Females 25 52.1
Age (years) 9.89 ? 5.21 5.75 ? 4.13 p=0.001
Duration of symptoms
before enrolment (days)
7.33 ? 4.89 5.75 ? 3.78 p=0.089
Fever duration before
enrolment (days)
5.50 ? 3.65 3.83 ? 2.93 p=0.021
Cough duration before
enrolment (days)
7.17 ? 4.89 5.01 ? 4.25 p=0.026
Date are presented as mean ? SD unless otherwise indicated.
Table 2 Comparison of the symptoms, signs and physical
findings between children with Mycoplasma pneumoniae
pneumonia and in children with pneumonia caused by









Fever 20 (83.3) 132 (93.0) p=0.117
Cough 24 (100.0) 118 (83.1) p=0.029
Coryza 4 (16.7) 36 (25.3) p=0.357
Difficulty breathing 2 (8.3) 16 (11.3) p=0.669
Headache 6 (25.0) 2 (1.4) p=0.001
Vomiting 4 (16.7) 30 (21.1) p=0.617
Tachypnoea 4 (16.7) 32 (22.5) p=0.649
Rales 8 (33.3) 40 (28.1) p=0.606
Wheezing 8 (33.3) 22 (15.5) p=0.036
Atopy or asthma 12 (50.0) 60 (42.3) p=0.479
Date are presented as number (%).
Medjo et al. Italian Journal of Pediatrics 2014, 40:104 Page 3 of 7
http://www.ijponline.net/content/40/1/104Definition of acute MP infection
Acute MP infection was defined if at least one method
was positive among detection of MP by culture or by
PCR or detection of MP-specific antibodies by serology.
Statistical analysis
Clinical data of the separate groups were described my
mean values and standard deviations or percentages, ac-
cording to the type of variable. Student ? s t-test and
ManneWhitney U-test were used to compare continuous
variables between the group and Chi-square test and
Fisher ? s exact test were used for categorical variables.
Furthermore, the variables resulting significant at the
univariate analysis were subjected to logistic regression
and odds ratios and their 95% confidence interval (CI)
were calculated. A p value of <0.05 was considered sta-
tistically significant. Sensitivity and specificity were cal-
culated using SS calculation comparing truly/falsely
positive/negative with frequencies of referent methods
(golden standard).
Results
Current study included 166 children with CAP. Among
them 86 (51.8%) were males and 80 (48.2%) were fe-
males (p=0.641). The mean age of the study population
was 6.35 ? 4.52 years, 88 (53.0%) children were less than
5 years old, while 78 (47.0%) were 5 ? 15 years old
(p=0.438). Mycoplasma pneumoniae pneumonia was di-
agnosed in 24 (14.5%) children according to our diag-
nostic criteria, with significant difference in the age
distribution, 25% of them were below 5 years and 75%
were 5 years and over (p=0.003). Mycoplasma pneumo-
niae infections were detected throughout the year. A
highest proportion of MP infections was recorded in the
autumn (33.3%), followed by 29.2% in winter, 25% in
spring and 12.5% in summer but the difference was not
statistically significant (p=0.506).
In our study MP infection was present in boys more
often than in girls (p=0.014). Children with MP pneu-
monia were significantly older (p=0.001), and had longer
duration of fever (p=0.021) and cough before enrolment
(p=0.026) compared to children with non-MP pneumo-
nia (Table 1).
Clinical characteristics of children in both groups were
further analyzed and compared. We found that cough
(p=0.029), headache (p=0.001) and wheezing (p=0.036)
were more frequent in children with MP pneumonia com-
pared to children with non-MP pneumonia (Table 2).
We did not observe other significant differences re-
garding symptoms, signs or physical findings between
these two groups (Table 2). The variables found to be
more frequent in children with MP pneumonia were
further analyzed by logistic regression. It was found that
headache (odds ratio [OR] =36.077, 95% confidenceinterval [CI] =4.897-265.811, p=0.001), wheezing (OR=5.681,
95% CI=1.776-18.175, p=0.003), mail gender (OR=0.162,
95% CI=0.048-0.548, p=0.003) and age 5 years and older
(OR=3.067, 95% CI=1.016-9.251, p =0.047) were signifi-
cantly associated with MP pneumonia.
The radiological findings in children with MP pneu-
monia were variable and summarized in Table 3. No
significant difference was observed in relation to the
radiological findings in the children with MP pneumonia
and those with pneumonia caused by other pathogens.
We noticed that unilateral lung involvements were more
often than bilateral in children with and without MP
infection (83.3% vs. 16.7%, 70.4% vs. 29.59%, p=0.191
Table 3 Comparison of the radiological characteristics
and laboratory data between children with Mycoplasma
pneumoniae pneumonia and in children with pneumonia









Linear opacities 12 (50.0) 83 (58.4)
Patchy infiltration 4 (16.7) 18 (12.7)
Segmental or lobar
consolidation
2 (8.3) 22 (15.5)
Interstitial infiltration 2 (8.3) 11 (7.7)
Reticulo-nodular infiltrate 2 (8.3) 6 (4.2)
Pleural effusion 2 (8.3) 2 (1.4)
WBC (109/L, mean ? SD) 13.20 ? 8.28 16.81 ? 10.51
Neutrophils (%) 69.37 ? 19.35 68.96 ? 18.60
Lymphocytis (%) 24.03 ? 17.25 24.88 ? 15.66
Monocytes (%) 5.82 ? 3.50 4.65 ? 2.73
Platelet (109/L, mean ? SD) 280.00 ?
109.37
273.83 ? 98.52
CRP (mg/L, mean ? SD) 51.75 ? 68.29 90.97 ? 96.92
Date are presented as number (%) unless otherwise indicated.
WBC: white blood cell count; CRP: C-reactive protein; * p < 0.05.
Figure 1 In a group of patients with Mycoplasma pneumoniae
pneumonia, percents of positive patients for each method.
RT-PCR: real-time polymerase chain reaction
Table 4 Mycoplasma pneumoniae detection by IgM
antibody testing, real-time polymerase chain reaction,
culture and IgG antibody titers in paired sera
IgG antibody titers in paired
sera with a fourfold increase,
Positive Negative
IgM resulte Positive 18 (10.84) 0 (0)
Negative 4 (2.41) 144 (86.75)
RT-PCR results Positive 18 (10.84) 2 (1.2)
Negative 4 (2.41) 142 (85.54)
Culture results Positive 18 (10.84) 0 (0)
Negative 4 (2.41) 144 (86.75)
Date are presented as number (%).
RT-PCR: real-time polymerase chain reaction.
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pneumonia had radiological findings on the right side
compared to 47.9% children with non-MP infection al-
though the difference did not reach statistical signifi-
cance (p=0.418). We did not find a difference in total
and differential WBC, platelet and CRP levels between
study groups (Table 3). There were no significant associ-
ations between radiological or laboratory findings and
MP infection as well.
Moreover, we analyzed group of children less than
5 years old and found that the proportion of MP pneu-
monia in this age group was 6.8%. Interestingly, in chil-
dren 5 years and older, 23.1% cases of CAP were caused
by MP. Additionally, we compared clinical characteris-
tics of children with MP pneumonia in these two groups
and found that 66.7% of children below 5 years had cor-
yza and 33.3% had difficulty breathing, while none of the
older children had those symptoms (p=0.001, p=0.011,
respectively). The younger children were more likely
than the older children to have tachypnoea (33.3% vs.
11.1%: p=0.031) as well. There were no other differences
regarding clinical characteristics, radiological or labora-
tory findings when these two groups of children were
compared.
Hospital admission between children with and without
MP pneumonia showed no differences (91.7% vs. 88.7%,p=0.669). However, children with MP infection had longer
total duration of fever and cough compared to children
with non-MP infection (6.33 ? 3.73 vs. 4.68 ? 3.23, p=0.02;
16.04 ? 5.38 vs. 8.32 ? 5.51, p=0.015 respectively) More-
over children with MP pneumonia had longer duration of
wheezing and length of hospitalization compared to chil-
dren with non-MP pneumonia (2.25 ? 3.33 vs. 0.59 ? 1.42,
p=0.001; 7.33 ? 3.40 vs. 3.48 ? 2.78, p=0.001 respectively).
None of children with MP pneumonia exhibited extrapul-
monary manifestations. All children recovered without
any of complication associated with MP infection.
Out of 24 children with MP pneumonia, 18 (75.0%)
were confirmed to be MP positive by serology, RT-PCR
and culture, 4 (16.7%) children were serologically positive
only and 2 (8.3%) were positive by RT-PCR only (Figure 1).
Real-time PCR was positive in 81.8% serologically positive
children. In all 20 RT-PCR positive children, the RT-PCR
was performed 7.8 ? 5.2 days after disease onset. A specific
IgM antibody response in acute-phase sera was detected
in 18 of 22 (81.8%) serologically positive children whose
Table 5 Diagnostic values of different methods with a fourfold or greater increase of IgG antibody titers in paired sera
as the gold standard
Sensitivity (%) Specificity (%) PPV (%) NPV (%) PLR
Serology (IgM antibodies) 81.82 100.00 100.00 97.30
RT-PCR 81.82 98.61 90.00 97.26 58.91
Culture 81.82 100.00 100.00 97.30
Date are presented as percentage.
RT-PCR: real-time polymerase chain reaction; PPV: positive predictive value; NPV: negative predictive value; PLR: positive likelihood ratio.
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onset. All 22 serologically positive children had fourfold
increase in IgG antibody titers in convalescent-phase sera.
The mean value of IgM and IgG were 1.65 ? 1.16 and
87.58 ? 40.77 respectively. Moreover, we compared diag-
nostic value of three different methods, IgM serology in
acute-phase sera, RT-PCR and culture, considering a four-
fold or greater increase of IgG antibody titers in paired sera
as the gold standard (Table 4). As shown in Table 5 sensi-
tivity and specificity of all three methods were similar. On
the contrary, when RT-PCR was considered as the gold
standard IgM serology had the lowest sensitivity (Table 6).
Additionally, we observed that combination of IgM detec-
tion in acute-phase serum and RT-PCR revealed positive
results for 22 (91.7%) of 24 cases with MP infection.
Discussion
In this study we assessed the incidence of MP pneumo-
nia, analyzed clinical, radiological and laboratory charac-
teristics of MP pneumonia and compared value of three
different diagnostic methods.
We found that 14.5% cases of CAP in Serbia were
caused by MP. Most hospital-based studies from Europe
reported similar frequencies of MP pneumonia with rates
ranging from 9% to 14% [6-11]. On the contrary, studies
from Asia reported higher prevalence of MP pneumonia
[12-15]. However, comparison with results obtained from
other studies is difficult due to the heterogeneity of the
epidemiologic conditions, studied population, diversity
in clinical specimens, and diagnostic methods applied.
Among MP positive children in present study, 75% were
children between 5? 15 years old. In accordance to our
data various studies reported that children 5 years and
older have a higher rate of MP infections compared to
younger children [6,9,10,16]. We observed that there wasTable 6 Diagnostic values of different methods with a real-tim
Sensitivity (%)
Serology (IgM antibodies) 80.00
Serology (fourfold increase IgG antibodies) 90.00
Culture 90.00
Date are presented as percentage.
RT-PCR: real-time polymerase chain reaction; PPV: positive predictive value; NPV: neno seasonal variation in MP infection which was also
found in studies performed in Italy and Tunis [17,18].
The clinical presentation of MP pneumonia observed in
our study did not differ from those described in other
studies [9,10,14,19]. One third of children with MP pneu-
monia had wheezing whereas fever and cough were the
most common symptoms. When we compared clinical
characteristics between children with MP pneumonia and
non-MP pneumonia, we found that cough, headache and
wheezing were more frequent in children with MP infec-
tion. Studies from Turkey and Brazil found that cough
was contributing finding to MP infection [16,20].
Higher incidence of wheezing in children with MP
pneumonia in our study could be due to the fact that half
of children with MP infection had asthma or atopy. How-
ever, children with non-MP pneumonia had high inci-
dence of asthma or atopy as well (42%) and no significant
difference was found between this two groups. Moreover,
logistic regression analysis showed that wheezing was sig-
nificantly associated with MP pneumonia. Italian study
found association between MP infection and wheezing in
children 5 years old and over [21]. Furthermore, we ob-
served that the radiological and laboratory findings did
not distinguish MP pneumonia from other CAP as re-
ported elsewhere [10,14,17]. Although the sample size of
children less than 5 years old was small, we found that
younger children more often had coryza, difficulty breath-
ing and tachypnoea which is in agreement with previous
reports [9,22]. The fact that all children below 5 years
were hospitalized and probably had more severe disease
could have contributed to this observation. Extrapulmon-
ary manifestations were not observed in present study as
previously reported [19].
Detection of IgM, in a single serum for diagnosis of
MP infection is considered significant in children thate polymerase chain reaction as the gold standard
Specificity (%) PPV (%) NPV (%) PLR
98.63 88.89 97.30 58.40
97.26 81.82 98.61 32.85
100.00 100.00 98.65
gative predictive value; PLR: positive likelihood ratio.
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sensitivity and specificity of IgM serology in present
study were 81.82%, and 100% respectively compared to
IgG serology and 80.00% and 98.63% respectively com-
pared to RT-PCR. Nadal et al. reported sensitivity and
specificity of IgM serology related to serology of 78.1%
and 87.1% respectively in children with MP pneumonia
[7]. Chang et al. used RT-PCR as a reference method
and observed that sensitivity and specificity of IgM ser-
ology were 62.2% and 85.5% respectively [24]. Sensitivity
of serology could be affected by timing of specimen col-
lection. This could explain high sensitivity of IgM ser-
ology in present study, considering that sera were taken
in the second week after disease onset. According to the
literature detection of IgG antibodies in paired sera is
more sensitive method, which was also confirmed by
our results [25].
Our results show that sensitivity and specificity of RT-
PCR compared to IgG serology were 81.82% and 98.61%
respectively. Nadal et al. found similar sensitivity and spe-
cificity of RT-PCR compared to serology in children with
MP pneumonia [7]. Morozumi et al. reported higher sen-
sitivity and similar specificity of RT-PCR related to ser-
ology, 90.2% and 97.9% respectively [26]. However, some
recent studies report lower sensitivity and specificity of
this method compared to IgM serology [24,27] and com-
pared to IgG serology [28,29]. This heterogeneity between
studies regarding sensitivity of PCR method could be due
to the different PCR types, different gene targets or differ-
ent sample type and time point for sampling [30]. Accord-
ing to the literature RT-PCR revealed higher sensitivity
compared to others types of PCR [30,31], but this could
only partially explain our results. Finally, we found that
combination of IgM detection in acute-phase serum and
RT-PCR was positive for 91.7% cases in children with MP
infection indicating a possible use of both techniques as a
valid diagnostic approach in early detection of MP infec-
tion in children with CAP.
However, present study showed some discrepancies be-
tween the results of the diagnostic methods used. The 4
cases of negative RT-PCR results with positive serology
may be due a disappearance, or a low level of MP load in
the sample [25]. The 2 positive RT-PCR results in sero-
logically negative children may be due to an inadequate
immune response or detection of a carrier state [32].
Our study had some limitations. One of them is the
small sample size. Besides, the results might be limited
due to the fact that children in this study were present-
ing to a tertiary children hospital, therefore patients with
more severe infections may have been overrepresented.
Furthermore, we did not perform extensive microbio-
logical testing, therefore we cannot exclude the possibil-
ity that some children might have had co-infections with
other bacterial or viral pathogens.Conclusions
The present study has shown that there are no charac-
teristic radiological findings, or routine laboratory tests
that would distinguish CAP caused by MP from other
CAP. Our results suggest that some clinical features are
indicative for MP pneumonia, such as headache and
wheezing and therefore may aid the process differentiat-
ing it from pneumonia cases caused by other pathogens.
However, detection of IgM antibodies together with RT-
PCR allows for precise and reliable diagnosis of MP in-
fections in children during the acute phases of disease,
indicating a possible use of both techniques as a valid
diagnostic approach in early detection of MP infection
in children with CAP.
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